MedPath

Mqupin Knee Patch Pain Relife

83778-004 Update V2

Approved
Approval ID

0977c119-f4e5-9ecf-e063-6294a90a30cc

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Mar 24, 2025

Manufacturers
FDA

Nanchang Dental Bright Technology Co.,Ltd.

DUNS: 544503502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Knee Patch Pain Relife

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code83778-004
Application NumberM017
Product Classification
M
Marketing Category
C200263
G
Generic Name
Knee Patch Pain Relife
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 24, 2025
FDA Product Classification

INGREDIENTS (9)

CINNAMON OILInactive
Code: E5GY4I6YCZ
Classification: IACT
BORNEOLActive
Quantity: 1.5 g in 100 1
Code: M89NIB437X
Classification: ACTIB
GRASS CARPInactive
Code: 9A3N315I11
Classification: IACT
ANREDERA CORDIFOLIA LEAFInactive
Code: MGE8MNJ5L6
Classification: IACT
MENTHOLActive
Quantity: 1 g in 100 1
Code: L7T10EIP3A
Classification: ACTIB
TURPENTINEInactive
Code: XJ6RUH0O4G
Classification: IACT
CAPSICUMInactive
Code: 00UK7646FG
Classification: IACT
LAUROCAPRAMInactive
Code: 1F3X9DRV9X
Classification: IACT
HOODIA GORDONII SAPInactive
Code: K7QNF2DJR8
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mqupin Knee Patch Pain Relife - FDA Drug Approval Details